Th ere is a clear evidence that same psychoactive substance may cause various individual physiological reactions in same environmental conditions. Although there is a general attitude on equal liability to opioid addiction, latest genetic analysis fi ndings imply there are certain quantifiable factors that could lead to elevated individual liability towards development of opioid addiction. Th e goal of this study was to investigate association of certain personality traits and genetic factors (separately and in combination) with heroin addiction. Total of  individuals participated in the study:  patients on Metadone Maintenance Treatment (MMT) and  age and sex matched healthy volunteers. All were medically examined, interviewed and psychologically evaluated using Eysenck personality questionnaire (EPQ) and genotyped for DRD (rs) using PCR-RFLP method. Overrepresentation of certain personality traits (neuroticism, psychoticism and extraversion/ intraversion), together with environemental risk factors such as: upbringing within incomplete families and familial history of psychotropic substances abuse, are associated with high-risk development of opioid addiction.
INTRODUCTION
Opiate addictions is major social and medical problem that impose a signifi cant burden on society. Opioids belong to group of psychoactive substances (PAS) , that are commonly abused and produce highly addictive eff ect. In any of the form of use (natural, semisynthetic or synthetic) -as opium, morphine, kodein or heroin, opioids cause signifi cant health deterioration and its consequences. Although they belong to central nervous system (CNS) sedating agents (sedatives), they cause an euphoria -aff ective state opposite to depression [] . According to the International Classification of Diseases,  th edition (ICD-) opioid addiction represents a cluster of behavioural, cognitive, and physiological symptoms developped after repeated opiods use. Opioid addiction typically includes a strong desire to take the drug, diffi culties in controlling its use and persistance in its use despite harmful consequences [] . Formal and molecular-genetic studies imply that genetic factors play a signifi cant role in susceptibility and interindividual variability of drug addiction [] . Although, it has been shown that there is an  fold increase in risk for opioid addiction development in fi rst degree relatives, it is not possible to exclude the contribution of environmental eff ects on particular personality traits linked to this disorder [] . Moreover, opioid substance abuse is at the most infl uenced by specifi c personality characteristics. Neurobiological mechanism of addiction is layed in disturbance of neurophysiological brain functions at reception and transmission of neuronal signals. After opioid intake, i.e. heroin, there is a change in physiologically controlled dopamine release. In longterm opioid addiction, the most important neurochemical mechanisms are prolonged depletion of opioid and dopamine transmission with qualitative and quantitative changes at opiod and dopamine receptors [] that affects the rewarding system and brain reinforcement [] . It has been shown that dopamine receptor type  (D) encoded by DRD gene (OMIM rs) is involved in liability to diff erent types of addiction: alcohol, nicotine, cocaine and heroin [] . Several structural changes within DRD have been found and explored as potentially causative variants in development of opioid addiction [] . DRD TaqI, a SNP also known as the TaqIA (or TaqA) polymorphism of the dopamine D receptor is represented with minor (T) and major (C) allele. Minor allele (Taq IA) is associated with a reduced number of dopamine binding sites in the brain and has been postulated to play a role in alcoholism, smoking, and certain neuropsychiatric disorders [] . Therefore we explored the variation of DRD gene polymorphism and personality traits and their potential association with inherited liability to opioid addiction.
MATERIALS AND METHODS

Patients
This research was prospectively conducted as case-control study and comprised sample of  individuals. Case group consisted of  patients included in Program of Metadone Substitution Therapy, previously diagnosed with opioid addiction according to ICD- and consecutively recruited during the period of one year. Control group contained  subjects clinically confirmed as healthy, with no individual history of substance abuse or psychiatric disorders, age and sex matched to case group individuals. Ethical aspects of the study were approved by institutional ethics committee and all participants signed informed consent prior to any study procedure.
Procedures
Psychological evaluation was performed for all individuals using Eysenck personality questionnaire (EPQ). Sociodemography data and family history was collected using study questionnaire followed by blood sampling for genetic analysis. DNA was extracted from blood using salting-out procedure [] followed by amplification of DRD TaqI (rs) fl anking region using previously reported method [] . PCR products were checked for quality on  agarose gel and subsequently treated with restriction endonuclease type II under following conditions: . unit of TaqI per microliter of PCR product was incubated at °C overnight. Restricted fragments were electrophoretically separated on  agarose gel and photodocumented using KODAK Edas Software.
Statistical analysis
Statistical analysis was performed using IBM Statistics -SPSS v. for Windows i Microsoft Excel .
RESULTS
Total of  individuals were recruited to the study under previously defined inclusion criteria. All signed informed consent and after being interviewed, provided blood sample for genetic analysis. DNA was succesfully extracted from all samples that all underwent standard PCR-RFLP procedure according to the protocol explained before. All expected genotypes AA, AA and AA have been observed in all individuals. Technician blinded to disease status read out and documented genotypes ( Figure ) . Frequencies of A and A alleles in both populations together were . and . respectively. Genotypes frequency distribution in whole observed population was , . and . for AA, AA and AA genotypes respectively. Sociodemographic parameters analysis showed statistically signifi cant diff erences between two investigated groups in relation to education level and employment status, work effi ciency, problems with law, upbringing conditions, parental marital status and intrafamilial relations. Among patients, . were upbrought by relatives,  individuals were abandoned. All control subjects were raised in primary families. Parental marital status diff ered between groups: . and . in case and control group respectively. . of patients' parents were widowers and . were divorced. Family history analysis implies statistically signifi cant diff er- ences between groups according to positive familial history for psychiatric disorders (psychoses and substance abuse) p<.. Alcohol abuse among fi rst degree relatives of study subjects was more frequent in case () than in control group ( Figure  ). Other substances abuse frequency was also increased among first degree relatives of study subjects:  and  in case and control group respectively. Psychotic and personality disorders of fi rst degree relatives were also overrepresented in case () than in control group () ( Figure ) . Analysis of primary personality traits determined the presence of high correlation between extraversion/intraversion, psychoticism and neuroticism in heroin abusers. Assessment of general distrubution of these traits pointed increased occurence of neuroticism among patients () as compared to control group (); similar pattern was shown for psychoticism ( in cases and  in controls), while intraversion was less overrepresented in case ( ) than in control group () ( Table ) . Analysis of investigated DRD locus genotypes showed a similar distribution of observed genotypes in both investigated groups. (Chi-square=.; p>.). Homozygous genotype variants (AA i AA) were overrepresented in case groups while heterozygotes were more frequently observed in control group, but no statistically significant difference was found ( Table ) . Analysis of genotype AA frequency showed  and  in case and control groups respectively ( Figure  No statistically significant association of DRD TaqI genotypes with any of the investigated personality traits in relation to addiction status. Multivariate analysis of parameters of sociodemography, heredity and A allele polymorphism, showed that patients -A allele carriers -with added factor of "up-bringing in incomplete family" has . fold increased risk for developing heroin addiction. Furthermore, patients with positive family history of psychosis and A allele carriers showed . fold increase in risk, while patients who had A allele and positive family history of drug abuse had even . times increase in risk for addiction than A/A carriers (Table ) .
DISCUSSION
Although current level of knowledge on opioid addiction implies equal liability to this disease, it is clear that certain inherited characteristics of personality play signifi cant role in development of heroin addiction. Results of this study inambiguosly showed that there is a clear overpresentation of basic personality traits (neuroticism, psychoticism, extraversion/intraversion) in group of patients with heroin addiction implying their role in elevation of disease risk as reported previously for different populations [-] .
A number of studies confi rmed an association between DRD polymorphism and heroin addiction [-] . Our study on DRD variation resulted with similar frequency distribution of observed genotypes in both investigated groups (Chisquare=.; p>.). However, homozygous genotypes (AA and AA) were overrepresented in case group, while heterozygotes (AA) were overrepresented in control group with no statistically signifi cant diff erence observed. Our fi ndings suggest that observation of certain genotype or allele variant (A) is not necessarily a single predictive factor for liability for opioid addiction, especially when others (i.e. certain personality trait or enviromental risk factors) are absent which is consistency with previously published data [,, ] . Considering the abovementioned, it is implicated that augmented values for personality traits (neuroticism, psychoticism, extraversion/intraversion and up-bringing in incomplete families) with factors of heredity (i.e. familial history of substance abuse and psychotic disorders) are associated with increased risk for development of opioid addiction. In this study we focused the variation in DRD gene with small additive effect in overall incidence of PAS abuse disorders, we can conclude that AA genotype associated with other sociodemographic and hereditary factors may increase individual risk towards opioid addiction development up to . fold as compared to AA non-carriers but with no direct association with heroin addiction.
CONCLUSION
Overrepresentation of certain personality traits (neuroticism, psychoticism and extraversion/ intraversion), together with environemental risk factors such as: upbringing within incomplete families and familial history of psychotropic substances abuse, are associated with high risk development of opioid addiction. AA genotype associated with other sociodemographic and hereditary factors may increase individual risk towards opioid addiction up to . fold as compared to AA non-carrier individuals. 
